Safety and Efficacy Study on Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease (PROTEGO-1 Study)
NCT05133180
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
104
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye
Interventions
DRUG:
Oxervate
OTHER:
Vehicle
Sponsor
Dompé Farmaceutici S.p.A